MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice ...

The U.S. Food and Drug Administration (FDA) has accepted for scientific review two Modified Risk Tobacco Product (MRTP) renewal applications from 22nd Century Group, a tobacco harm reduction company ...

22nd Century announces readiness to support the FDA's proposed standard to reduce nicotine content in cigarettes. The possible regulation passed review by the U.S. Office of Management and Budget on ...

CLARENCE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, today announced X-22, a prescription smoking ...

MOCKSVILLE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a ...

On Monday, the company announced an agreement to fund all intellectual property, licensing and sponsored research payments to North Carolina State University through 2025 in equity as part of a deal ...

MOCKSVILLE, N.C., April 29, 2026 (GLOBE NEWSWIRE)-- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the ...

Detailed price information for 22nd Century Group Inc (XXII-Q) from The Globe and Mail including charting and trades.

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (OTCBB:XXII) today announced that it has purchased all of the equipment at a cigarette manufacturing facility in Mocksville, North Carolina.

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has launched a new ...